Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Postbiotics as a therapeutic frontier in Parkinson's disease: Insights into molecular pathways and neuroprotective effects.

Kumari A, Aran KR.

Metab Brain Dis · 2026-09-09

DOI: 10.1007/s11011-026-01978-7PMID: 42714731

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial.

Chen X, Luo K, Liu X, Ye N, Lin W, Liu Z, Cheng X, Huang Z, Xiao Y, Zeng H, Lian Y, Zhang Y, Li M, Huang S, Wang Z, Wang X, Zhang L, Lin H, Zhang Y, Chen Q, Wang D, Ni J, Wang N, Fu Y, Gan S, OSCCAR Investigators.

Brain Stimul · 2026-09-09

DOI: 10.1016/j.brs.2026.103205PMID: 42716220

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Probiotic Spore Inspired Oral Drug Delivery System With Multiple-Barriers-Crossing Ability Modulates Gut-Brain Axis for Parkinson's Disease Therapy.

Feng Q, Mei Y, Zhang J, Sun L, Si B, Zhou H, Xiao H, Liu R, Zhang J, Wang L.

Exploration (Beijing) · 2026-09-09

DOI: 10.1002/exp2.70221PMID: 42719630

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Microbiome-Gut-Brain Axis: Decoding the Molecular Dialogue for Next-Generation Neurotherapeutics.

Nadeem MS, Rahman S, Murtaza BN, Al-Zharani M, Afzal M, Nasr FA, Iftikhar S, Chaieb K, Alzarea SI, Kazmi I.

Curr Neuropharmacol · 2026-09-09

DOI: 10.2174/011570159x491341260902051725PMID: 42736672

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson's Disease.

Dhinakaran K, Sivaperuman A, Natarajan R, Kesavan Y, Nagarajan NC, Solomon VR.

Curr Top Med Chem · 2026-09-09

DOI: 10.2174/0115680266472132260829141305PMID: 42736675

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Role of cGAS-STING-Driven PANoptosis in Neurodegenerative Diseases and Therapeutic Prospects.

Hou X, Yu W.

Cells · 2026-09-09

DOI: 10.3390/cells15181631PMID: 42782733

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts.

Barbosa R, Bastos P, Rascol O, Corvol JC, Fabienne OM, Brefel-Courbon C, Leung C, Mariani LL, Defebvre L, Carriere N, Giordana C, Heraud C, Laurencin C, Prange S, Remy P, Hopes L, Houeto JL, Prin P, Thiriez C, De Maindreville AD, Benatru I, Corbille AG, di Legge S, Lagha-Boukbiza O, Schneider V, Grimaldi S, Castelnovo G, Tir M, Maltête D, Foubert-Samier A, Marques A, Drapier S, Fabbri M, French NS-Park network.

Neurology · 2026-09-09

DOI: 10.1212/wnl.0000000000218515PMID: 42715510

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation.

Mittal D, Solanki P, Jain GK, Jhawat V, Kesharwani P, Dutt R, Arora S, Singh RP.

3 Biotech · 2026-09-09

DOI: 10.1007/s13205-026-05048-8PMID: 42719214

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation.

Mona MM, Borg HM, Ahmed AA, Abass SA, El-Kholy SS.

Sci Rep · 2026-09-08

DOI: 10.1038/s41598-026-68289-wPMID: 42711364

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease.

Ríos-Gallardo A, Herrera-Ramirez D, Bastias-Candia S, Inestrosa NC.

Molecules · 2026-09-08

DOI: 10.3390/molecules31183139PMID: 42796428

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy.

Perales MA, Dietrich J, Gust J, Santomasso B, Rejeski K, Hansen D, Shah NN, Berdeja J, Bishop M, Bleickardt E, Brudno J, Dahiya S, Frey N, Frigault MJ, Gardner R, Ghobadi A, Grupp S, Hamadani M, Jacobson C, Jain MD, Jain T, Komanduri KV, Kumar A, Lim S, Lin Y, Miao H, Neelapu S, Otegbeye F, Park JH, Pasquini M, Patel N, Plautz G, Verdun N, Lee DW, Maus MV, Locke FL.

Transplant Cell Ther · 2026-09-08

DOI: 10.1016/j.jtct.2026.05.020PMID: 42711241

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Boehringer A, Kalia LV, Bloem BR, Kordower JH.

J Parkinsons Dis · 2026-09-07

DOI: 10.1177/1877718x261486172PMID: 42706618

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

20.491 makale bulundu

Postbiotics as a therapeutic frontier in Parkinson's disease: Insights into molecular pathways and neuroprotective effects.

Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial.

Probiotic Spore Inspired Oral Drug Delivery System With Multiple-Barriers-Crossing Ability Modulates Gut-Brain Axis for Parkinson's Disease Therapy.

The Microbiome-Gut-Brain Axis: Decoding the Molecular Dialogue for Next-Generation Neurotherapeutics.

A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson's Disease.

The Role of cGAS-STING-Driven PANoptosis in Neurodegenerative Diseases and Therapeutic Prospects.

Levodopa Use and Characteristics of Freezing-of-Gait in Patients With Parkinson Disease in the NS-Park and PPMI Cohorts.

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation.

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation.

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease.

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy.

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies.

Filtreler